301033 迈普医学
已收盘 02-13 15:00:00
资讯
新帖
简况
Osteopore与Medprin Biotech GmbH达成独家合作，布局拉丁美洲分销网络
美股速递 · 02-13 06:00
Osteopore与Medprin Biotech GmbH达成独家合作，布局拉丁美洲分销网络
2月5日迈普医学发布公告，股东减持3.01万股
证券之星 · 02-05
2月5日迈普医学发布公告，股东减持3.01万股
迈普医学(301033.SZ)股东唐莹拟减持不超84.09万股
智通财经 · 02-03
迈普医学(301033.SZ)股东唐莹拟减持不超84.09万股
2月2日迈普医学涨8.35%，大成价值增长混合A基金重仓该股
证券之星 · 02-02
2月2日迈普医学涨8.35%，大成价值增长混合A基金重仓该股
迈普医学：公司早期在3D打印技术方面有所布局
证券之星 · 01-23
迈普医学：公司早期在3D打印技术方面有所布局
股市必读：迈普医学（301033）1月21日董秘有最新回复
证券之星 · 01-22
股市必读：迈普医学（301033）1月21日董秘有最新回复
迈普医学（301033）披露公司实际控制人、控股股东部分股份解除质押的公告，1月13日股价下跌0.48%
证券之星 · 01-13
迈普医学（301033）披露公司实际控制人、控股股东部分股份解除质押的公告，1月13日股价下跌0.48%
迈普医学（301033）披露公司实际控制人、控股股东部分股份质押的公告，1月7日股价下跌4.92%
证券之星 · 01-07
迈普医学（301033）披露公司实际控制人、控股股东部分股份质押的公告，1月7日股价下跌4.92%
迈普医学（301033）股东袁玉宇质押155万股，占总股本2.31%
证券之星 · 01-07
迈普医学（301033）股东袁玉宇质押155万股，占总股本2.31%
迈普医学创60日新高，中邮证券一个月前给出“买入”评级
证券之星 · 01-05
迈普医学创60日新高，中邮证券一个月前给出“买入”评级
异动快报：迈普医学（301033）1月5日10点17分触及涨停板
证券之星 · 01-05
异动快报：迈普医学（301033）1月5日10点17分触及涨停板
迈普医学拟3.35亿元收购易介医疗100%股权，布局神经介入领域
中金财经 · 2025-12-25
迈普医学拟3.35亿元收购易介医疗100%股权，布局神经介入领域
迈普医学（301033）披露公司首发前股东减持股份计划实施完成公告，12月15日股价上涨2.28%
证券之星 · 2025-12-15
迈普医学（301033）披露公司首发前股东减持股份计划实施完成公告，12月15日股价上涨2.28%
12月12日增减持汇总：迈普医学等7家公司减持 无A股增持（表）
新浪证券 · 2025-12-12
12月12日增减持汇总：迈普医学等7家公司减持 无A股增持（表）
迈普医学最新公告：股东国寿成达减持1.00%股份
证券之星 · 2025-12-12
迈普医学最新公告：股东国寿成达减持1.00%股份
迈普医学(301033.SZ)股东深圳凯盈、风炎基金拟减持不超1.22%股份
智通财经 · 2025-12-12
迈普医学(301033.SZ)股东深圳凯盈、风炎基金拟减持不超1.22%股份
12月5日迈普医学现683.87万元大宗交易
证券之星 · 2025-12-05
12月5日迈普医学现683.87万元大宗交易
迈普医学实际控制人袁玉宇解除质押221万股股份
中金财经 · 2025-12-01
迈普医学实际控制人袁玉宇解除质押221万股股份
迈普医学（301033）披露公司章程（2025年11月），11月21日股价下跌3.02%
证券之星 · 2025-11-21
迈普医学（301033）披露公司章程（2025年11月），11月21日股价下跌3.02%
迈普医学（301033）披露公司实际控制人、控股股东部分股份解除质押的公告，11月19日股价下跌1.63%
证券之星 · 2025-11-19
迈普医学（301033）披露公司实际控制人、控股股东部分股份解除质押的公告，11月19日股价下跌1.63%
暂无数据
公司概况
公司名称：
广州迈普再生医学科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2021-07-26
主营业务：
广州迈普再生医学科技股份有限公司的主营业务是医疗器械的研发、生产与销售。公司的主要产品是人工硬脑（脊）膜补片、颅颌面修补及固定系统、可吸收再生氧化纤维素及硬脑膜医用胶。
发行价格：
15.14
{"stockData":{"symbol":"301033","market":"SZ","secType":"STK","nameCN":"迈普医学","latestPrice":73.07,"timestamp":1770966231000,"preClose":73.5,"halted":0,"volume":583360,"delay":0,"changeRate":-0.0059,"floatShares":56469100,"shares":67049600,"eps":1.5199,"marketStatus":"已收盘","change":-0.43,"latestTime":"02-13 15:00:00","open":73.51,"high":74,"low":72.65,"amount":42801800,"amplitude":0.0184,"askPrice":73.09,"askSize":2,"bidPrice":73.07,"bidSize":5,"shortable":0,"etf":0,"ttmEps":1.5199,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771896600000},"marketStatusCode":5,"adr":0,"adjPreClose":73.5,"symbolType":"stock","openAndCloseTimeList":[[1770946200000,1770953400000],[1770958800000,1770966000000]],"highLimit":80.85,"lowLimit":66.15,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":67049620,"isCdr":false,"pbRate":6.56,"roa":"--","peRate":48.075531,"roe":"10.43%","epsLYR":1.2,"committee":0.625,"marketValue":4899000000,"turnoverRate":0.0103,"status":1,"floatMarketCap":4126000000},"requestUrl":"/m/hq/s/301033/tweets","defaultTab":"tweets","newsList":[{"id":"1176904243","title":"Osteopore与Medprin Biotech GmbH达成独家合作，布局拉丁美洲分销网络","url":"https://stock-news.laohu8.com/highlight/detail?id=1176904243","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176904243?lang=zh_cn&edition=full","pubTime":"2026-02-13 06:00","pubTimestamp":1770933607,"startTime":"0","endTime":"0","summary":"再生医学公司Osteopore宣布，已与德国Medprin Biotech GmbH签订独家合作协议，旨在共同开拓拉丁美洲市场。通过此次合作，Osteopore旗下的3D打印生物支架产品将正式进入该地区，为颅颌面外科及神经外科手术提供创新解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["301033","OSX.AU","BK0251","BK7126"],"gpt_icon":0},{"id":"2609832091","title":"2月5日迈普医学发布公告，股东减持3.01万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2609832091","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609832091?lang=zh_cn&edition=full","pubTime":"2026-02-05 17:27","pubTimestamp":1770283650,"startTime":"0","endTime":"0","summary":"证券之星消息，2月5日迈普医学发布公告《迈普医学:关于持股5%以上股东权益变动触及1%的提示性公告》，其股东深圳市凯盈科技有限公司于2026年1月14日至2026年2月5日间合计减持3.01万股，占公司目前总股本的0.0449%，变动期间该股股价下跌3.19%，截止2月4日收盘报72.85元。股东增减持详情见下表：根据迈普医学2025年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500028001.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2608273698","title":"迈普医学(301033.SZ)股东唐莹拟减持不超84.09万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608273698","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608273698?lang=zh_cn&edition=full","pubTime":"2026-02-03 18:51","pubTimestamp":1770115879,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迈普医学(301033.SZ)公告，公司股东唐莹女士计划通过集中竞价交易及大宗交易方式减持公司股份不超过84.09万股，占公司总股本的1.2541%。减持期间为自本公告披露之日起15个交易日后的3个月内。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401132.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301033","BK0251"],"gpt_icon":0},{"id":"2608585107","title":"2月2日迈普医学涨8.35%，大成价值增长混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608585107","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608585107?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:56","pubTimestamp":1770022603,"startTime":"0","endTime":"0","summary":"证券之星消息，2月2日迈普医学涨8.35%，收盘报73.7元，换手率5.5%，成交量3.11万手，成交额2.23亿元。重仓迈普医学的前十大公募基金请见下表：该股最近90天内共有5家机构给出评级，买入评级3家，增持评级2家；过去90天内机构目标均价为90.6。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共14家，其中持有数量最多的公募基金为大成基金的大成价值增长混合A。该公募基金现任基金经理为杨挺。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200023828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2605415494","title":"迈普医学：公司早期在3D打印技术方面有所布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2605415494","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605415494?lang=zh_cn&edition=full","pubTime":"2026-01-23 09:03","pubTimestamp":1769130187,"startTime":"0","endTime":"0","summary":"证券之星消息，迈普医学01月22日在投资者关系平台上答复投资者关心的问题。投资者提问：董，你好，请问最近出台的这个3d打印医疗设备。公司早期在3D打印技术方面有所布局，主要是用于体外组织模型或活体组织构建等前沿科学及临床应用研究。3D打印技术在医疗领域的应用，能够为患者提供更加个体化和精准的治疗方案，有助于提高治疗效果，使患者受益。公司将也持续关注政策动态。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300007175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2605482422","title":"股市必读：迈普医学（301033）1月21日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2605482422","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605482422?lang=zh_cn&edition=full","pubTime":"2026-01-22 02:20","pubTimestamp":1769019620,"startTime":"0","endTime":"0","summary":"截至2026年1月21日收盘，迈普医学报收于72.82元，上涨2.05%，换手率2.49%，成交量1.41万手，成交额1.02亿元。董秘最新回复投资者： 董秘好，公司产品是不是供应Neuralink脑机接口公司手术产业？如果不方便说，请问公司产品有应用于脑机接口手术中吗？公司将持续关注新兴产业、未来产业的技术发展方向。当日关注点来自交易信息汇总：1月21日主力资金净流出635.63万元，显示主力短期态度偏谨慎。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200000933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","BK0251"],"gpt_icon":0},{"id":"2603884507","title":"迈普医学（301033）披露公司实际控制人、控股股东部分股份解除质押的公告，1月13日股价下跌0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603884507","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603884507?lang=zh_cn&edition=full","pubTime":"2026-01-13 17:47","pubTimestamp":1768297621,"startTime":"0","endTime":"0","summary":"截至2026年1月13日收盘，迈普医学报收于75.25元，较前一交易日下跌0.48%，最新总市值为50.45亿元。近日，广州迈普再生医学科技股份有限公司发布公告，公司实际控制人、控股股东袁玉宇先生所持部分股份已办理了解除质押登记手续。解除质押后，袁玉宇累计被质押股份为4,150,000股，占其所持股份比例37.45%。公司表示，上述解除质押行为不会导致实际控制权变更，对生产经营和公司治理无重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300030300.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","BK0251"],"gpt_icon":0},{"id":"2601124809","title":"迈普医学（301033）披露公司实际控制人、控股股东部分股份质押的公告，1月7日股价下跌4.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601124809","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601124809?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:14","pubTimestamp":1767795265,"startTime":"0","endTime":"0","summary":"截至2026年1月7日收盘，迈普医学报收于76.2元，较前一交易日下跌4.92%，最新总市值为51.09亿元。同日，公司发布公告称，实际控制人、控股股东袁玉宇先生将其持有的1,550,000股公司股份质押给深圳市高新投集团有限公司，用于个人融资。本次质押占其所持股份比例的13.99%，占公司总股本的2.31%。公司实际控制人及其一致行动人合计持股32.82%，累计质押股份占公司总股本的9.52%。上述质押行为不会导致公司控制权变更，股份不存在被冻结或平仓风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700038772.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2601874683","title":"迈普医学（301033）股东袁玉宇质押155万股，占总股本2.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601874683","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601874683?lang=zh_cn&edition=full","pubTime":"2026-01-07 18:35","pubTimestamp":1767782144,"startTime":"0","endTime":"0","summary":"证券之星消息，迈普医学1月7日公开信息显示，股东袁玉宇向深圳市高新投集团有限公司合计质押155.0万股，占总股本2.31%。质押详情见下表：截止本公告日，股东袁玉宇已累计质押股份638.0万股，占其持股总数的57.81%，股东袁美福已累计质押股份60.0万股，占其持股总数的20.65%。迈普医学主营业务：从事神经外科领域的高性能植入医疗器械的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700031231.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2601600654","title":"迈普医学创60日新高，中邮证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2601600654","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601600654?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:46","pubTimestamp":1767599193,"startTime":"0","endTime":"0","summary":"今日迈普医学（301033）创60日新高，收盘报81.0元。2025年11月13日，中邮证券研究员盛丽华,陈峻发布了对迈普医学的研报《业绩符合预期，收购易介拓宽天花板》，该研报对迈普医学给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为76.51%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为华创证券的李婵娟、郑辰。迈普医学（301033）个股概况：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015837.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","161027"],"gpt_icon":0},{"id":"2601079882","title":"异动快报：迈普医学（301033）1月5日10点17分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2601079882","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601079882?lang=zh_cn&edition=full","pubTime":"2026-01-05 10:20","pubTimestamp":1767579635,"startTime":"0","endTime":"0","summary":"证券之星1月5日盘中消息，10点17分迈普医学触及涨停板。其所属行业医疗器械目前上涨。领涨股为翔宇医疗。该股为脑科学，医疗器械，口腔概念热股，当日脑科学概念上涨11.44%，医疗器械概念上涨3.46%，口腔概念上涨3.06%。12月31日的资金流向数据方面，主力资金净流入247.58万元，占总成交额9.75%，游资资金净流入63.57万元，占总成交额2.5%，散户资金净流出311.14万元，占总成交额12.26%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500006845.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2594321522","title":"迈普医学拟3.35亿元收购易介医疗100%股权，布局神经介入领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2594321522","media":"中金财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594321522?lang=zh_cn&edition=full","pubTime":"2025-12-25 21:19","pubTimestamp":1766668773,"startTime":"0","endTime":"0","summary":"根据方案，迈普医学拟以33,484.94万元的总对价，通过发行股份及支付现金的方式，向泽新医疗等10名交易对方购买其持有的广州易介医疗科技有限公司100%股权。本次交易构成关联交易，但不构成重大资产重组及重组上市。交易完成后，易介医疗将成为迈普医学的全资子公司，有助于上市公司将生物材料技术延伸至神经介入医疗器械领域，拓展产品线并整合销售渠道。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251225/31892637.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["159891","301033","BK0251"],"gpt_icon":0},{"id":"2591610814","title":"迈普医学（301033）披露公司首发前股东减持股份计划实施完成公告，12月15日股价上涨2.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591610814","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591610814?lang=zh_cn&edition=full","pubTime":"2025-12-15 18:12","pubTimestamp":1765793537,"startTime":"0","endTime":"0","summary":"截至2025年12月15日收盘，迈普医学报收于67.33元，较前一交易日上涨2.28%，最新总市值为45.14亿元。该股当日开盘64.9元，最高68.39元，最低64.9元，成交额达6186.58万元，换手率为1.63%。近日，迈普医学发布关于公司首发前股东减持股份计划实施完成的公告。本次减持计划已实施完成，符合相关法律法规及承诺，未导致公司控制权变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500024143.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2590745509","title":"12月12日增减持汇总：迈普医学等7家公司减持 无A股增持（表）","url":"https://stock-news.laohu8.com/highlight/detail?id=2590745509","media":"新浪证券","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590745509?lang=zh_cn&edition=full","pubTime":"2025-12-12 21:02","pubTimestamp":1765544520,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 据统计，12月12日，盘后迈普医学、盈新发展（维权）、西陇科学（维权）、亚翔集成、梦百合、永鼎股份、金辰股份等7家A股上市公司披露减持情况。当日暂无上市公司披露增持情况。\n\n\n新浪声明：此消息系转载自新浪合作媒体，新浪网登载此文出于传递更多信息之目的，并不意味着赞同其观点或证实其描述。文章内容仅供参考，不构成投资建议。投资者据此操作，风险自担。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2025-12-12/doc-inhaqapf5042580.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0251","301033","399300","159982"],"gpt_icon":0},{"id":"2590023506","title":"迈普医学最新公告：股东国寿成达减持1.00%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2590023506","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590023506?lang=zh_cn&edition=full","pubTime":"2025-12-12 20:50","pubTimestamp":1765543827,"startTime":"0","endTime":"0","summary":"迈普医学(301033.SZ)公告称，股东国寿成达通过集中竞价交易方式减持公司股份67.05万股，占公司总股本的1.0000%，减持期间为2025年12月2日至2025年12月11日，减持价格区间为62.99元/股至65.60元/股，减持股份来源为首次公开发行前取得的股份。本次减持后，国寿成达持有公司股份比例由1.8969%降至0.8969%。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200037897.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2590067905","title":"迈普医学(301033.SZ)股东深圳凯盈、风炎基金拟减持不超1.22%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2590067905","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590067905?lang=zh_cn&edition=full","pubTime":"2025-12-12 20:49","pubTimestamp":1765543796,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迈普医学(301033.SZ)公告，公司收到公司股东深圳凯盈、风炎基金分别出具的《关于计划减持股份的告知函》，深圳凯盈拟减持不超过15万股，即不超过公司总股本的0.2237%;风炎基金拟减持不超过66.81万股，占公司当前股本的0.9964%(占剔除公司回购专用账户后总股本的1.0000%)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381136.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301033","BK0251"],"gpt_icon":0},{"id":"2589893687","title":"12月5日迈普医学现683.87万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2589893687","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589893687?lang=zh_cn&edition=full","pubTime":"2025-12-05 17:42","pubTimestamp":1764927766,"startTime":"0","endTime":"0","summary":"证券之星消息，12月5日迈普医学发生大宗交易，交易数据如下：大宗交易成交价格62.17元，相对当日收盘价折价1.51%，成交11万股，成交金额683.87万元，买方营业部为中信证券股份有限公司北京呼家楼证券营业部，卖方营业部为国信证券股份有限公司深圳泰然九路证券营业部。近三个月该股共发生1笔大宗交易，合计成交1100.0手，折价成交1笔。截至2025年12月5日收盘，迈普医学报收于63.12元，上涨0.8%，换手率0.63%，成交量3542.0手，成交额2221.62万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500027325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2588239527","title":"迈普医学实际控制人袁玉宇解除质押221万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2588239527","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588239527?lang=zh_cn&edition=full","pubTime":"2025-12-01 17:22","pubTimestamp":1764580938,"startTime":"0","endTime":"0","summary":"中访网数据 广州迈普再生医学科技股份有限公司于近日发布公告，公司实际控制人、控股股东袁玉宇先生将其持有的部分公司股份办理了解除质押手续。本次解除质押股份数量为221万股，占其所持公司股份比例的19.94%，占公司总股本的3.30%。其中，袁玉宇先生累计质押股份数量为483万股，占其个人所持股份的43.59%，占公司总股本的7.20%；徐弢先生所持股份目前无质押情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251201/31835690.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2585141439","title":"迈普医学（301033）披露公司章程（2025年11月），11月21日股价下跌3.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585141439","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585141439?lang=zh_cn&edition=full","pubTime":"2025-11-21 22:54","pubTimestamp":1763736864,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，迈普医学报收于63.0元，较前一交易日下跌3.02%，最新总市值为42.24亿元。该股当日开盘64.7元，最高65.33元，最低62.78元，成交额达3413.56万元，换手率为0.95%。近日，迈普医学发布公告称，公司对《广州迈普再生医学科技股份有限公司章程》进行了修订。章程明确公司注册资本为67,049,620.00元，股份总数为普通股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100041161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2584947117","title":"迈普医学（301033）披露公司实际控制人、控股股东部分股份解除质押的公告，11月19日股价下跌1.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584947117","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584947117?lang=zh_cn&edition=full","pubTime":"2025-11-19 22:35","pubTimestamp":1763562923,"startTime":"0","endTime":"0","summary":"迈普医学于近日发布公告，公司实际控制人、控股股东袁玉宇先生将其所持有的1,040,000股公司股份办理了解除质押手续，占其所持股份比例9.39%，占公司总股本比例1.55%，质权人为深圳市高新投小额贷款有限公司。本次解除质押后，袁玉宇累计质押股份为7,040,000股，占其所持股份比例63.53%。截至公告日，公司实际控制人及其一致行动人所持股份无冻结或拍卖情况，质押股份无平仓风险，不会导致公司控制权变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900040253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770998695619,"stockEarnings":[{"period":"1week","weight":0.0338},{"period":"1month","weight":-0.0233},{"period":"3month","weight":0.0442},{"period":"6month","weight":-0.1368},{"period":"1year","weight":0.5805},{"period":"ytd","weight":0.0889}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":-0.0011},{"period":"3month","weight":0.036},{"period":"6month","weight":0.1183},{"period":"1year","weight":0.2354},{"period":"ytd","weight":0.0416}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广州迈普再生医学科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"6043人(较上一季度减少2.36%)","perCapita":"9344股","listingDate":"2021-07-26","address":"广东省广州市黄埔区崖鹰石路3号","registeredCapital":"6704万元","survey":" 广州迈普再生医学科技股份有限公司的主营业务是医疗器械的研发、生产与销售。公司的主要产品是人工硬脑（脊）膜补片、颅颌面修补及固定系统、可吸收再生氧化纤维素及硬脑膜医用胶。","listedPrice":15.14},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迈普医学(301033)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迈普医学(301033)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迈普医学,301033,迈普医学股票,迈普医学股票老虎,迈普医学股票老虎国际,迈普医学行情,迈普医学股票行情,迈普医学股价,迈普医学股市,迈普医学股票价格,迈普医学股票交易,迈普医学股票购买,迈普医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迈普医学(301033)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迈普医学(301033)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}